Administrative Core
行政核心
基本信息
- 批准号:10733193
- 负责人:
- 金额:$ 7.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary – Administrative Core A
The Administrative Core is designed to provide scientific leadership, effective communication, and an
administrative support structure to ensure the coordination of all PDX Development and Trial Center (PDTC)
activities. The essential services provided by the Core include: administrative support for all of the investigators
in each project and core; scientific oversight and progress review for each project; coordination of selection
processes for Pilot Studies and integration of these investigators and their projects into the PDXNet program
as they evolve; fiscal and financial management and oversight for all components of the PDTC; and
organization and communication of all PDTC meetings and activities. The Administrative Core is also
responsible for all interactions with the NCI staff, both scientific and administrative.
The overall objectives of the Administrative Core are to:
1. Establish and maintain an administrative structure to provide support for and management of all PDTC
activities.
2. Foster an environment to maximize collaborative and translational research among PDTC investigators
between Wistar, MD Anderson, and Penn and between other PDTC/PDXNet and NCI initiatives.
3. Ensure compliance with all institutional, governmental, and NCI regulations and policies.
项目摘要 - 行政核心A
行政核心旨在提供科学领导,有效的沟通和
行政支持结构,以确保所有PDX开发与试验中心(PDTC)的协调
活动。核心提供的基本服务包括:所有调查人员的行政支持
在每个项目和核心中;每个项目的科学监督和进度审查;选择协调
试点研究的过程和这些研究者及其项目纳入PDXNET计划的过程
随着它们的发展; PDTC所有组件的财政和财务管理和监督;和
所有PDTC会议和活动的组织和沟通。行政核心也是
负责与NCI员工的所有互动,无论是科学还是行政管理。
行政核心的总体对象是:
1。建立和维护管理结构,为所有PDTC提供支持和管理
活动。
2。培养一个环境,以最大化PDTC调查人员之间的协作和翻译研究
在Wistar,MD Anderson和Penn之间以及其他PDTC/PDXNET和NCI计划之间。
3.确保遵守所有机构,政府和NCI法规和政策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Jessie Villanueva的其他基金
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
靶向 S6K2 克服 NRAS 突变黑色素瘤的耐药性
- 批准号:1053983010539830
- 财政年份:2022
- 资助金额:$ 7.92万$ 7.92万
- 项目类别:
Functional precision approaches to overcome intrinsic and acquired drug resistance in melanoma
克服黑色素瘤内在和获得性耐药性的功能精确方法
- 批准号:1073319610733196
- 财政年份:2017
- 资助金额:$ 7.92万$ 7.92万
- 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:86340818634081
- 财政年份:2013
- 资助金额:$ 7.92万$ 7.92万
- 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:90540869054086
- 财政年份:2013
- 资助金额:$ 7.92万$ 7.92万
- 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:88267118826711
- 财政年份:2013
- 资助金额:$ 7.92万$ 7.92万
- 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:92464469246446
- 财政年份:2013
- 资助金额:$ 7.92万$ 7.92万
- 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:84880468488046
- 财政年份:2013
- 资助金额:$ 7.92万$ 7.92万
- 项目类别:
相似国自然基金
以家庭为中心的癌症患儿多症状管理模式的构建及干预:基于症状管理理论的实证研究
- 批准号:71704106
- 批准年份:2017
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目